Proclara Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2006-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.proclarabio.com
Clinical Trials
5
Active:0
Completed:4
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Multiple Ascending Dose Study in Healthy Subjects
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2019-08-19
- Lead Sponsor
- Proclara Biosciences, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03879278
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
A Study of NPT189 in Healthy Subjects
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Proclara Biosciences, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03610035
- Locations
- 🇳🇱
PRA Health Sciences, Groningen, Netherlands
Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Proclara Biosciences, Inc.
- Target Recruit Count
- 83
- Registration Number
- NCT03008161
- Locations
- 🇺🇸
ATP Clinical Research, Inc., Costa Mesa, California, United States
🇺🇸Neurology Center of North Orange County, Fullerton, California, United States
🇺🇸Collaborative Neuroscience Network, Long Beach, California, United States
News
No news found